296 related articles for article (PubMed ID: 15611632)
41. Assembling an orchestra: Fanconi anemia pathway of DNA repair.
Yuan F; Song L; Qian L; Hu JJ; Zhang Y
Front Biosci (Landmark Ed); 2010 Jun; 15(3):1131-49. PubMed ID: 20515746
[TBL] [Abstract][Full Text] [Related]
42. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
43. Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group.
Ali AM; Kirby M; Jansen M; Lach FP; Schulte J; Singh TR; Batish SD; Auerbach AD; Williams DA; Meetei AR
Hum Mutat; 2009 Jul; 30(7):E761-70. PubMed ID: 19405097
[TBL] [Abstract][Full Text] [Related]
44. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
Garcia-Higuera I; Taniguchi T; Ganesan S; Meyn MS; Timmers C; Hejna J; Grompe M; D'Andrea AD
Mol Cell; 2001 Feb; 7(2):249-62. PubMed ID: 11239454
[TBL] [Abstract][Full Text] [Related]
45. Regulation of the Fanconi anemia pathway by monoubiquitination.
Gregory RC; Taniguchi T; D'Andrea AD
Semin Cancer Biol; 2003 Feb; 13(1):77-82. PubMed ID: 12507559
[TBL] [Abstract][Full Text] [Related]
46. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
47. Repair pathways independent of the Fanconi anemia nuclear core complex play a predominant role in mitigating formaldehyde-induced DNA damage.
Noda T; Takahashi A; Kondo N; Mori E; Okamoto N; Nakagawa Y; Ohnishi K; Zdzienicka MZ; Thompson LH; Helleday T; Asada H; Ohnishi T
Biochem Biophys Res Commun; 2011 Jan; 404(1):206-10. PubMed ID: 21111709
[TBL] [Abstract][Full Text] [Related]
48. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.
Chandrasekharappa SC; Lach FP; Kimble DC; Kamat A; Teer JK; Donovan FX; Flynn E; Sen SK; Thongthip S; Sanborn E; Smogorzewska A; Auerbach AD; Ostrander EA;
Blood; 2013 May; 121(22):e138-48. PubMed ID: 23613520
[TBL] [Abstract][Full Text] [Related]
49. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
[TBL] [Abstract][Full Text] [Related]
50. The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer target.
Sharp MF; Bythell-Douglas R; Deans AJ; Crismani W
Mol Cell; 2021 Jun; 81(11):2278-2289. PubMed ID: 33984284
[TBL] [Abstract][Full Text] [Related]
51. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
Taniguchi T; Tischkowitz M; Ameziane N; Hodgson SV; Mathew CG; Joenje H; Mok SC; D'Andrea AD
Nat Med; 2003 May; 9(5):568-74. PubMed ID: 12692539
[TBL] [Abstract][Full Text] [Related]
52. A novel ubiquitin ligase is deficient in Fanconi anemia.
Meetei AR; de Winter JP; Medhurst AL; Wallisch M; Waisfisz Q; van de Vrugt HJ; Oostra AB; Yan Z; Ling C; Bishop CE; Hoatlin ME; Joenje H; Wang W
Nat Genet; 2003 Oct; 35(2):165-70. PubMed ID: 12973351
[TBL] [Abstract][Full Text] [Related]
53. Functional interplay between BRCA2/FancD1 and FancC in DNA repair.
Kitao H; Yamamoto K; Matsushita N; Ohzeki M; Ishiai M; Takata M
J Biol Chem; 2006 Jul; 281(30):21312-21320. PubMed ID: 16687415
[TBL] [Abstract][Full Text] [Related]
54. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2.
Schlacher K; Wu H; Jasin M
Cancer Cell; 2012 Jul; 22(1):106-16. PubMed ID: 22789542
[TBL] [Abstract][Full Text] [Related]
55. Molecular biology of Fanconi anaemia--an old problem, a new insight.
Ahmad SI; Hanaoka F; Kirk SH
Bioessays; 2002 May; 24(5):439-48. PubMed ID: 12001267
[TBL] [Abstract][Full Text] [Related]
56. [Pathogenesis of Fanconi anemia: FA-BRCA network -- review].
Li YS; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):805-9. PubMed ID: 19549413
[TBL] [Abstract][Full Text] [Related]
57. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.
Wang X; Andreassen PR; D'Andrea AD
Mol Cell Biol; 2004 Jul; 24(13):5850-62. PubMed ID: 15199141
[TBL] [Abstract][Full Text] [Related]
58. Assessing the link between BACH1 and BRCA1 in the FA pathway.
Cantor SB; Andreassen PR
Cell Cycle; 2006 Jan; 5(2):164-7. PubMed ID: 16357529
[TBL] [Abstract][Full Text] [Related]
59. Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.
Litim N; Labrie Y; Desjardins S; Ouellette G; Plourde K; Belleau P; ; Durocher F
Mol Oncol; 2013 Feb; 7(1):85-100. PubMed ID: 23021409
[TBL] [Abstract][Full Text] [Related]
60. Fanconi anaemia and cancer: an intricate relationship.
Nalepa G; Clapp DW
Nat Rev Cancer; 2018 Mar; 18(3):168-185. PubMed ID: 29376519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
